ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

HYL Hyloris Pharmaceuticals SA

11.70
-0.15 (-1.27%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Hyloris Pharmaceuticals SA HYL Euronext Ordinary Share
  Price Change Price Change % Share Price Last Trade
-0.15 -1.27% 11.70 10:40:00
Open Price Low Price High Price Close Price Previous Close
11.90 11.70 11.90 11.70 11.85
more quote information »

Recent News

Date Time Source Heading
3/14/202401:00GLOBEHyloris Reports Full Year Results for 2023 & Provides..
3/14/202400:59GLOBECommuniqué à la requête de la FSMA sur les transactions avec..
3/08/202400:00GLOBEHyloris to Report 2023 Full-Year Results on 14 March 2024
2/27/202411:00GLOBEHyloris Announces Launch of Maxigesic® IV in the U.S. and..
2/14/202411:00GLOBEHyloris Recrute un Premier Patient dans le Cadre d'un Essai..
1/30/202400:00GLOBEHyloris et Purna Female Healthcare Annoncent des Résultats..
1/18/202412:00GLOBEHyloris Elargit son Portefeuille de Produits avec un Nouveau..
1/16/202412:30GLOBELa FDA Américaine Accorde la Qualification de Médicament..
1/16/202410:30GLOBEPleco Therapeutics receives FDA Orphan Drug Designation
12/26/202311:00GLOBEHyloris Annonce des Résultats Cliniques Positifs pour son..
12/21/202311:30GLOBEHyloris élargit son Portefeuille avec un Nouveau Produit..
12/04/202300:00GLOBEHyloris annonce l'approbation du Gel Podofilox par la FDA..
10/24/202300:00GLOBEHyloris annonce un accord de licence pour l'Atomoxetine Oral..
9/06/202315:00GLOBEHyloris Pharmaceuticals Reports 2023 Half-Year Results and..
6/22/202300:00GLOBEHyloris annonce le recrutement d’un premier patient pour son..
6/13/202310:59GLOBEHyloris shareholders approve all resolutions at the Annual..
6/08/202310:59GLOBEHyloris Pharmaceuticals perçoit 1 million € de financement..
5/02/202300:00GLOBEHyloris announces potential registration date for Maxigesic®..
4/28/202300:00GLOBEHyloris publie son rapport annuel 2022 et ses objectifs ESG

Your Recent History

Delayed Upgrade Clock